[Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002219:Carbamates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007463:Iodobenzoates / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011247:Pregnancy; D013964:Thyroid Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D001549:Benzamides; D002219:Carbamates; D007463:Iodobenzoates; D009943:Organophosphorus Compounds
Rezul'taty klinicheskogo izucheniia preparata diĭodbenzotéf pri zlokachestvennykh opukholiakh